Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score
Satoshi Kitai(Kindai University), Takashi Matsunaga(Osaka International Cancer Institute), Yasunori Minami, Yo Sasaki(SHOWA Medical University), Seiji Haji(Kindai University), Hiroshi Kasugai(Osaka International Cancer Institute), Yukio Osaki(Osaka Red Cross Hospital), Masatoshi Kudo(Kindai University), Hiroko Oka(Osaka City General Hospital), Toshihito Seki(Kansai Medical University)
Cited by 73
Related Papers
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k